Association of genetic variations in genes implicated in the axis with outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with cetuximab plus chemotherapy.

Yuji Miyamoto,Sebastian Stintzing,Volker Heinemann,Wu Zhang,Shu Cao,Satoshi Okazaki,Martin D. Berger,Mitsukuni Suenaga,Marta Schirripa,Shivani Soni,Satoshi Matsusaka,Yan Ning,Dongyun Yang,Roel Gopez,Elizabeth Melendez,Diana L. Hanna,Afsaneh Barzi,Hideo Baba,Heinz-Josef Lenz

Association of genetic variations in genes implicated in the axis with outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with cetuximab plus chemotherapy.

2017

Yuji Miyamoto
Sebastian Stintzing
Volker Heinemann
Wu Zhang
Shu Cao
Satoshi Okazaki
Martin D. Berger
Mitsukuni Suenaga
Marta Schirripa
Shivani Soni
Satoshi Matsusaka
Yan Ning
Dongyun Yang
Roel Gopez
Elizabeth Melendez
Diana L. Hanna
Afsaneh Barzi
Hideo Baba
Heinz-Josef Lenz

3585Background: Accumulating evidence suggests that right- and left-sided CRCs have different prognoses and different sensitivities to EGFR inhibitors in several phase3 trials. These differences mi...

Keywords:

Cetuximab
Genetic variation
Pathology
Cancer research
Gene
Colorectal cancer
Medicine
Chemotherapy
in patient
Oncology
Internal medicine
EGFR inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations